The human ether-à-go-go related gene (hERG) inhibition at 1uM of a drug with the SMILES CCN1CCN(Cc2ccc(NC(=O)c3cc(NC(=O)c4cncc(-c5cccs5)c4)cc(OC)c3)cc2C(F)(F)F)CC1.O=C(O)C(F)(F)F is 11.139\%.
The {herg_central_at_1uM__names__noun} of a {#drug|compound!} with the {SMILES__description} {SMILES#} is {herg_central_at_1uM#}{herg_central_at_1uM__units}.
CCN1CCN(Cc2ccc(NC(=O)c3cc(NC(=O)c4cncc(-c5cccs5)c4)cc(OC)c3)cc2C(F)(F)F)CC1.O=C(O)C(F)(F)F
CCN1CCN(Cc2ccc(NC(=O)c3cc(NC(=O)c4cncc(-c5cccs5)c4)cc(OC)c3)cc2C(F)(F)F)CC1.O=C(O)C(F)(F)F
N-[3-[[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoyl]-5-methoxyphenyl]-5-thiophen-2-ylpyridine-3-carboxamide;2,2,2-trifluoroacetic acid